Sen. Sheldon Whitehouse sold Ionis Pharmaceuticals (IONS)
Sen. Sheldon Whitehouse (D-RI) · $1K–$15K · traded Jan 20, 2016
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- The member
- Traded
- Jan 20, 2016
- Disclosed
- Feb 23, 2016
- Days to disclose
- 34
- Asset type
- Stock
- As filed
- Ionis Pharmaceuticals, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Feb 23, 2016$1K–$15K
Bought ProShares S&P 500 Dynamic Buffer ETF FB
$1K–$15K · Traded Feb 16, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$1K–$15K
$1K–$15K · Traded Feb 12, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$1K–$15K
$1K–$15K · Traded Feb 12, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$1K–$15K
Bought JPMORGAN CHASE & CO 6.12% FIXED Rate/Coupon: 6.12% Matures: 02/12/2056
$1K–$15K · Traded Feb 5, 2016 · disclosed Feb 23, 2016 · Spouse
- Feb 23, 2016$1K–$15K
Bought Twitter, Inc. (delisted) TWTR
$1K–$15K · Traded Feb 1, 2016 · disclosed Feb 23, 2016
- Feb 23, 2016$1K–$15K
Bought ProShares S&P 500 Dynamic Buffer ETF FB
$1K–$15K · Traded Jan 28, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$1K–$15K
Bought Twitter, Inc. (delisted) TWTR
$1K–$15K · Traded Jan 26, 2016 · disclosed Feb 23, 2016 · Spouse
- Feb 23, 2016$15K–$50K
$15K–$50K · Traded Jan 20, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$15K–$50K
Sold (full) Canadian Pacific Kansas City CP
$15K–$50K · Traded Jan 20, 2016 · disclosed Feb 23, 2016 · Joint
- Feb 23, 2016$15K–$50K
Sold (full) Canadian Pacific Kansas City CP
$15K–$50K · Traded Jan 20, 2016 · disclosed Feb 23, 2016
- Feb 23, 2016$1K–$15K
$1K–$15K · Traded Jan 20, 2016 · disclosed Feb 23, 2016
Recent Congress trades in IONS
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Ionis Pharmaceuticals IONS
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
Company context for IONS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
IONS: third_quarter 2026 lobbying report
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Public: Oct 19, 2026, 7:29 AM EDTOriginal source ↗IONS: third_quarter 2026 lobbying report
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy. Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.
Public: Oct 15, 2026, 4:28 PM EDTOriginal source ↗IONS: second_quarter 2026 lobbying report
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law. Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Public: Jul 17, 2026, 1:48 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.